HSD92 Natural Language Processing (NLP) of Unstructured EMR Data to Describe Treatment Patterns and Achievement of Guideline Recommended LDL-C Targets of Canadian Patients with Ascvd and Hypercholesterolemia

Autor: LA Leiter, AL Lavoie, GBJ Mancini, F Leblond, C Rojas-Fernandez, T Bandukwala

Publikováno v: Value in Health. 25:S495-S496

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cbd92e635c868573bc7647a806491e28
https://doi.org/10.1016/j.jval.2022.04.1092

HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management

Autor: GBJ Mancini, AL Lavoie, LA Leiter, C Rojas-Fernandez, F Leblond, T Bandukwala

Publikováno v: Value in Health. 25:S485

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::619f0f7a7dcd2888669f03aed21fa3da
https://doi.org/10.1016/j.jval.2022.04.1033

Outcomes of Percutaneous Coronary Intervention in Patients with Spontaneous Coronary Artery Dissection.

Autor: Hassan, Saber¹ (AUTHOR), Samuel, Rohit¹ (AUTHOR), Starovoytov, Andrew¹ (AUTHOR), Lee, Carolyn¹ (AUTHOR), Aymong, Eve¹ (AUTHOR), Saw, Jacqueline¹ (AUTHOR)

Publikováno v: Journal of Interventional Cardiology. 5/17/2021, p1-9. 9p.

Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).

Autor: Penson PE; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK.; Liverpool Centre for Cardiovascular Science, Liverpool, UK., Bruckert E; Pitié-Salpetrière Hospital and Sorbonne University, Cardio metabolic Institute, Paris, France., Marais D; Chemical Pathology Division of the Department of Pathology, University of Cape Town Health Science Faculty, Cape Town, South Africa., Reiner Ž; Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine University of Zagreb, Zagreb, Croatia., Pirro M; Department of Medicine, University of Perugia, Perugia, Italy., Sahebkar A; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.; Clinic of Cardiology, University Clinical Centre of Kosova, Medical Faculty, University of Prishtina, Prishtina, Kosovo., Bajraktari G; Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.; Department of Internal Disease, Kyrgyz State Medical Academy, Bishkek, Kyrgyzstan., Mirrakhimov E; Department of Atherosclerosis and Coronary Heart Disease, National Center of Cardiology and Internal Diseases, Bishkek, Kyrgyzstan., Rizzo M; Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.; Division of Endocrinology, Diabetes and Metabolism, School of Medicine, University of South Carolina, Columbia, SC, USA., Mikhailidis DP; Department of Clinical Biochemistry, University College London Medical School, University College London (UCL), London, UK., Sachinidis A; Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.; 2nd Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece., Gaita D; Universitatea de Medicina si Farmacie Victor Babes, Timisoara, Romania.; Clinica de Cardiologie, Institutul de Boli Cardiovasculare Timisoara, Timisoara, Romania., Latkovskis G; Pauls Stradins Clinical University Hospital, Riga, Latvia.; University of Latvia, Riga, Latvia., Mazidi M; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK.; Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK., Toth PP; CGH Medical Center, Sterling, IL, USA.; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pella D; 2nd Department of Cardiology of the East Slovak Institute of Cardiovascular Disease and Faculty of Medicine, PJ Safarik University, Kosice, Slovak Republic., Alnouri F; Cardiovascular Prevention Unit, Adult Cardiology Department, Prince Sultan Cardiac Centre Riyadh, Riyadh, Saudi Arabia., Postadzhiyan A; Department of General Medicine, Emergency University Hospital 'St. Anna', Medical University of Sofia, Sofia, Bulgaria., Yeh HI; Department of Medicine, MacKay Medical College, New Taipei City, Taiwan., Mancini GBJ; Department of General Medicine, Emergency University Hospital 'St. Anna', Medical University of Sofia, Sofia, Bulgaria., von Haehling S; Department of Cardiology and Pneumology, Heart Center, University of Göttingen Medical Center, Göttingen, Germany.; German Center for Cardiovascular Research (DZHK), partner site Göttingen, Göttingen, Germany., Banach M; Polish Moother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.; Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland.; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland.

Publikováno v: Journal of cachexia, sarcopenia and muscle [J Cachexia Sarcopenia Muscle] 2022 Jun; Vol. 13 (3), pp. 1596-1622. Date of Electronic Publication: 2022 Mar 10.

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases - A position paper from the International Lipid Expert Panel (ILEP).

Autor: Ruscica M; Department of Pharmacology and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy., Penson PE; School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, UK; Liverpool Centre for Cardiovascular Science, Liverpool, UK., Ferri N; Department of Pharmaceutical and Pharmacological Sciences, Università degli Studi di Padova, Padova, Italy., Sirtori CR; Department of Pharmacology and Biomolecular Sciences, Università degli Studi di Milano, Milano, Italy., Pirro M; Internal Medicine Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy., Mancini GBJ; Center for Cardiovascular Innovation, University of British Columbia, Vancouver, BC, Canada., Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom., Toth PP; Cicarrone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sahebkar A; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran., Lavie CJ; Department of Medicine, John Ochsner Medical Center, New Orleans, LA, USA., Wong ND; Heart Disease Prevention Program, Division of Cardiology, University of California Irvine, Irvine, CA, USA., Banach M; Department of Hypertension, Medical University of Lodz (MUL), Lodz, Poland; Cardiovascular Research Centre, University of Zielona Gora, Zielona Gora, Poland. Electronic address: maciej.banach@umed.lodz.pl.

Publikováno v: Progress in cardiovascular diseases [Prog Cardiovasc Dis] 2021 Jul-Aug; Vol. 67, pp. 40-52. Date of Electronic Publication: 2021 Jun 27.